Ashiya M, Grabowski P J
Howard Hughes Medical Institute and Department of Biological Sciences, University of Pittsburgh, Pennsylvania 15260, USA.
RNA. 1997 Sep;3(9):996-1015.
Tissue- and stage-specific alternative splicing events are widespread in mammals, yet the factors and mechanisms that direct these important posttranscriptional events are poorly understood. In this study, we focus on the 24-nt exon of the GABA(A) receptor gamma2 pre-mRNA, which is subject to neuron-specific and developmental splicing regulation in the rat cerebellum. Here we show biochemical evidence for a mechanism that directs the selective repression of the neuron-specific exon in non-neuronal splicing extracts derived from HeLa cells. Key evidence includes the discovery that the pathway of gamma2 pre-mRNA splicing switches from exon skipping to exon selection in splicing reactions with a short RNA competitor containing the 3' splice site region upstream of the 24-nt exon. In this assay, exon selection results from the coordinate activation of both flanking introns. A detailed dissection of this pre-mRNA region shows that it contains four repressor sites clustered around the branch site and extending into the 24-nt exon. These repressor sites are pyrimidine rich and bind avidly to the polypyrimidine tract binding protein (PTB) in HeLa nuclear extracts as determined by UV crosslinking/competition assays. Repression of the exon selection pathway is closely associated with the appearance of a specific RNA-protein complex, indicative of an inhibitor complex, that assembles on the repressor array. Upon the switch to the exon selection pathway, a substantial decrease in the inhibitor complex and a reciprocal increase in spliceosome complex A is observed. Excess recombinant PTB squelches the splicing switch and reestablishes exon skipping as the predominant splicing pathway. Extracts prepared from rat brain nuclei show reduced levels of conventional PTB compared to other splicing factors. Nonetheless, the rat brain nuclear extracts contain an activity that assembles an analogous inhibitor complex efficiently. We report a 59-kDa protein, p59, which has an electrophoretic mobility distinct from HeLa and rat kidney PTB, and which behaves in RNA binding assays as if it is the PTB counterpart in rat brain. Evidence that rat brain p59 is structurally related to PTB stems from western blot and immunoprecipitation analysis with a monoclonal antibody specific for the hnRNP I isoform of PTB. A model describing how the repressor array directs coordinate splicing regulation of flanking introns in the context of overlapping positive regulatory elements is discussed. The sequence, (5') UUCUCU (3'), in a pyrimidine context is associated with one class of intron splicing repressor sites that binds PTB in a variety of pre-mRNAs that are regulated by tissue-specific programs.
组织和阶段特异性可变剪接事件在哺乳动物中广泛存在,然而,指导这些重要转录后事件的因素和机制却知之甚少。在本研究中,我们聚焦于GABA(A)受体γ2前体mRNA的24核苷酸外显子,其在大鼠小脑中受到神经元特异性和发育性剪接调控。在此,我们展示了一种机制的生化证据,该机制在源自HeLa细胞的非神经元剪接提取物中指导神经元特异性外显子的选择性抑制。关键证据包括发现γ2前体mRNA剪接途径在与含有24核苷酸外显子上游3'剪接位点区域的短RNA竞争剂的剪接反应中从外显子跳跃转变为外显子选择。在该实验中,外显子选择源于两侧内含子的协同激活。对该前体mRNA区域的详细剖析表明,它包含四个围绕分支位点聚集并延伸至24核苷酸外显子的抑制位点。这些抑制位点富含嘧啶,通过紫外线交联/竞争实验确定,它们在HeLa细胞核提取物中与多嘧啶序列结合蛋白(PTB)紧密结合。外显子选择途径的抑制与一种特定RNA - 蛋白质复合物的出现密切相关,该复合物表明是一种抑制剂复合物,它在抑制子阵列上组装。当转变为外显子选择途径时,观察到抑制剂复合物大量减少,剪接体复合物A相应增加。过量的重组PTB抑制剪接转换并重新确立外显子跳跃作为主要的剪接途径。与其他剪接因子相比,从大鼠脑细胞核制备的提取物显示常规PTB水平降低。尽管如此,大鼠脑细胞核提取物含有一种能有效组装类似抑制剂复合物的活性。我们报道了一种59 kDa的蛋白质p59,其电泳迁移率与HeLa和大鼠肾PTB不同,并且在RNA结合实验中的行为表明它是大鼠脑中PTB的对应物。大鼠脑p59与PTB在结构上相关的证据源于用针对PTB的hnRNP I同工型的单克隆抗体进行的蛋白质印迹和免疫沉淀分析。讨论了一个模型,该模型描述了在重叠的正调控元件背景下,抑制子阵列如何指导两侧内含子的协同剪接调控。在嘧啶背景下的序列(5')UUCUCU(3')与一类内含子剪接抑制位点相关,这些位点在多种受组织特异性程序调控的前体mRNA中与PTB结合。